CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$55.43 -0.01 (-0.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Long-Term Investments (2016 - 2025)

Updated

CRISPR Therapeutics AG (CRSP) reported Long-Term Investments of $28.41 million for Q3 2025.

Analysis

CRISPR Therapeutics AG (CRSP) Long-Term Investments (2016 - 2025) Analysis & Trends

At the end of FY2023, CRISPR Therapeutics AG posted Long-Term Investments of $2 million, down 96.2% from FY2022.

  • By year, Long-Term Investments came in at $53.13 million in FY2022.
  • The Q3 2025 figure ranks as the highest quarterly Long-Term Investments since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 CRISPR Therapeutics AG 5.36 Bn 5.36 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 28.41 Mn
Jun 30, 2024 11.22 Mn
Dec 31, 2023 2.00 Mn
Jun 30, 2023 4.90 Mn
Mar 31, 2023 6.32 Mn
Dec 31, 2022 53.13 Mn
Sep 30, 2022 77.15 Mn
Jun 30, 2022 8.40 Mn
Sep 30, 2016 35.69 Mn
API Access

CRISPR Therapeutics AG Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CRSP&period=max&api_key=YOUR_API_KEY